Mbkacin 250 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Urinary Tract Infection. The alternative uses of Mbkacin 250 Injection have also been explained below.
The optimal dosage of Mbkacin 250 Injection is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Some other side effects of Mbkacin 250 Injection have been listed ahead. Normally, these side effects of Mbkacin 250 Injection are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Mbkacin 250 Injection's effect during pregnancy is Severe and Unknown while nursing. Further, the section on Mbkacin 250 Injection related warnings talks about Mbkacin 250 Injection's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Dehydration, Parkinson's Disease, Hearing Loss must refrain from the use of Mbkacin 250 Injection since this can cause severe adverse effects. Other conditions have been mentioned below in the Mbkacin 250 Injection contraindications section.
Drug reaction of Mbkacin 250 Injection with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Mbkacin 250 Injection is safe while driving, and is addiction.
Mbkacin 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Mbkacin 250 Injection is used -
Moderate
Mild
Unknown
Is the use of Mbkacin 250 Injection safe for pregnant women?
Mbkacin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Mbkacin 250 Injection safe during breastfeeding?
There is no research available on the side effects of Mbkacin in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Mbkacin 250 Injection on the Kidneys?
Effects of Mbkacin on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of Mbkacin 250 Injection on the Liver?
Side effects of Mbkacin rarely affect the liver.
What is the effect of Mbkacin 250 Injection on the Heart?
Side effects of Mbkacin rarely affect the heart.
Mbkacin 250 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Mbkacin 250 Injection unless your doctor advises you to do so -
Is this Mbkacin 250 Injection habit forming or addictive?
Mbkacin 250 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Mbkacin 250 Injection since it does not cause drowsiness.
Is it safe?
Mbkacin 250 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Mbkacin 250 Injection cannot treat any kind of mental disorder.
Interaction between Food and Mbkacin 250 Injection
You can take Mbkacin 250 Injection with food.
Interaction between Alcohol and Mbkacin 250 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Mbkacin 250 Injection with alcohol will be.
Yes, Mbkacin is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Mbkacin taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Mbkacin with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
Occasionally, Mbkacin can cause drug-induced thrombocytopenia (blood clot formation in the vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Mbkacin is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Yes, Mbkacin has been reported to cause ototoxicity (hearing loss or deafness) which is irreversible and may progress after discontinuation of the drug. It is a common side effect of this medicine. If you experience hearing loss or deafness after consuming or applying for this medicine, then consult your doctor and follow his/her instructions.
No, Mbkacin does not cause constipation in patients who are taking it. However, if you are experiencing constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
